Edition:
United Kingdom

Acer Therapeutics Inc (ACER.OQ)

ACER.OQ on NASDAQ Stock Exchange Capital Market

23.64USD
18 Oct 2018
Change (% chg)

-- (--)
Prev Close
$23.64
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
12,590
52-wk High
$34.10
52-wk Low
$11.45

Chart for

About

Acer Therapeutics Inc., formerly Opexa Therapeutics, Inc., is a pharmaceutical company. The Company is engaged in acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need. Its late-stage clinical pipeline includes Edsivo (celiprolol) and ACER-001. The... (more)

Overall

Beta: 2.33
Market Cap(Mil.): $12.90
Shares Outstanding(Mil.): 0.74
Dividend: --
Yield (%): --

Financials

  ACER.OQ Industry Sector
P/E (TTM): -- 85.68 33.65
EPS (TTM): -7.59 -- --
ROI: -141.39 0.45 14.28
ROE: -141.39 1.37 16.00

Earnings vs. Estimates